¶ … Cognitive Testing
SAGE Cognitive Test for Detecting Early Signs of Alzheimer's
The Self-Administered Gerocognitive Examination, also known as the SAGE test is meant for at-home administration by older adults in order to test the strength of their memory and other cognitive functioning. It was originally designed by researchers at Ohio State University's Wexner Medical Center. Dr. Douglas Scharre from the Wexner Medical School created the test and published it in early 2014. Essentially, it is "designed to detect early signs of cognitive, memory or thinking impairments" (Scharre, 2014). It is meant for individuals to self administer at home when they feel they may be worried about loosing cognitive functioning, which can be a sign of early Alzheimer's disease or Dementia. The test takes roughly about 15 minutes to complete and can be used as a way to start a dialogue with one's physician regarding potential for such conditions and how individuals can begin treating and preparing for them early on. The test is meant to warn individuals and their physicians of possible issues that could be related to the early onset of Alzheimer's or dementia, as well as a variety of other conditions known to impact cognitive functioning, like mild strokes and thyroid conditions. Here, the research suggests that the "SAGE can be a helpful tool to assess if further evaluation is necessary" (Scharre, 2014). It is an easy to use cognitive test that can extrapolate red flags that would suggest the need for further evaluation.
The test itself is deceptively simple and can be printed out and taken at home by individuals potentially worried about their cognitive functioning. The test is meant for senior citizens, normally from 65 years of age and older. It features a total of 22 questions that are written on paper by the test takers (Alzheimer's &...
Alzheimer's Disease currently affects more than four million Americans. Alzheimer's is a disease characterized by the progressive degeneration of areas within the brain, resulting in cognitive and physical decline that will eventually lead to death. It is important to emphasize that Alzheimer's disease (AD) is not a normal part of aging. Although AD typically appears in those over sixty-five, it is a neurodegenerative disease, quite distinct from any aging-related cognitive
Alzheimer's disease has developed into a major health concern for the elderly population throughout the world. This degenerative brain disorder was first described by Alois Alzheimer in 1907. Today Alzheimer's is one of the most prevalent forms of brain disorders contributing to as much as 50 to 70% of all reported cases of dementia. Over the years the study of early onset Alzheimer's disease (pre-senile AD) has kind of overshadowed
One area that was missed in the literature was the effectiveness of various intervention strategies in reducing stress in families with persons with disabilities. It is not known what interventions have been tried and which ones were most effective in helping families to build coping mechanisms and reduce stress. This is the obvious next step into developing a thorough understanding of the topic area. This literature review revealed several key trends
) Researcher believe that when Alzheimer's begins to attack, it hits the "factory" of cell groups that otherwise are functioning perfectly. There are breakdowns in the communications that the cell groups hitherto provided, and although scientists don't know precisely where the attack is first launched by Alzheimer's, but they do understand that "as the damage spreads, cells lose their ability to do their jobs and, eventually die, causing irreversible changes
A. Harvard Women's Health Watch (2010) Preserving and improving memory as we age. Feb 1: NA B. This is an article that is written directly to consumers who are over the age of 50 and are starting to notice changes in the ability to remember things. It addresses the fact that this wrongly causes fear in some people that they are prone toward Alzheimer's disease. Studies have shown that cognitive decline
As expected, NIHSS scores indicated mild stroke severity, while the FIM scores suggested moderate motor deficits. A comparison of the demographic variables for the patients that met the inclusion criteria with those that did not, revealed no significant differences except in terms of stroke severity, laterality, and comprehension impairment. The results of the cognitive evaluations (MMSE vs. MoCA, r = .79, p < .001; MMSE vs. cFIM, r = .56,
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now